Provera
indicated for hormonal therapy to address reproductive health concerns and to support endometrial stability.
Strengths: 5 · 10mg
Where to Check Availability
Medicine details
- Therapeutic class
Progestogens
- Pharmacological class
Progestogen
- Minor side effects
nausea; headache; fatigue; breast tenderness
- Moderate side effects
insomnia; dizziness; weight changes; menstrual irregularities
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Pfizer
- Onset Time
1–3 days
- Duration
24 hours
- Storage instructions
Store below 25°C in a dry place.
- Drug interactions
aminoglutethimide
- Age restrictions
Not indicated for paediatric use.
Contraindications
undiagnosed vaginal bleeding; severe hepatic impairment; history of breast cancer; pregnancy
Precautions and warnings
monitor for signs of thrombotic disorders; use caution in patients with history of depression; risk of fluid retention
Serious side effects
thromboembolism — requires immediate medical attention; anaphylaxis — requires immediate medical attention
Patient summary
indicated for hormonal therapy to address reproductive health concerns and to support endometrial stability.
Mechanism of action
A synthetic progestogen that acts on the endometrium, transforming proliferative tissue into secretory tissue and providing hormonal balance for various gynaecological indications.
Pregnancy and breastfeeding
Pregnancy: Must not be used during pregnancy. Breastfeeding: Excreted in breast milk; consult your physician.
Provera
indicated for hormonal therapy to address reproductive health concerns and to support endometrial stability.
Editorial Notes
- Active ingredient(s): Medroxyprogesterone
- Listed indication(s): Endometriosis, Secondary Amenorrhea, Abnormal Uterine Bleeding
Available option
- 90 tablets - 10 mg475-10-mg-3984